Enterprise Value
159.6M
Cash
123.3M
Avg Qtr Burn
-19.81M
Short % of Float
23.44%
Insider Ownership
0.97%
Institutional Own.
-
Qtr Updated
07/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sebetralstat (KVD900) (film coated) Details Hereditary angioedema , Rare diseases, Rare genetic disease Big Mover™ Suspected Mover™ Susp. Mover™ | Phase 3 Data readout | |
KVD001 (IVT) Details Diabetic macular edema, Frontotemporal dementia with C9orf72 mutation, Dementia, Diabetes | Failed Discontinued | |
KVD824 (plasma kallikrein enzyme inhibitor) Details Hereditary angioedema , Rare diseases, Rare genetic disease | Failed Discontinued |